Picture of Fresenius Medical Care AG & Co KGaA logo

FME Fresenius Medical Care AG & Co KGaA Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Momentum

Relative Strength (%)
1m+8.66%
3m+15.57%
6m-7.12%
1yr-40.62%
Volume Change (%)
10d/3m-17.69%
Price vs... (%)
52w High-44.85%
50d MA+12.59%
200d MA-8.7%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.15
PEG Ratio (f)n/a
EPS Growth (f)-7.55%
Dividend Yield (f)3.06%
Valuation (ttm)IndustryMarket
Price to Book Value0.68
Price to Tang. Bookn/a
Price to Free Cashflow6.15
Price to Sales0.54
EV to EBITDA7.42

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5.02%
Return on Equity5.6%
Operating Margin8.45%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue€m17,783.5716,546.8717,476.5617,859.0617,618.6919,373.6820,161.331.24%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+25.7+0.4-10.59+6.71-19.11-20.39-7.55n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Fresenius Medical Care AG & Co KGaA EPS forecast chart

Profile Summary

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
February 10th, 2006
Public Since
February 25th, 2008
No. of Employees
122,758
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
de flag iconXETRA
Shares in Issue
293,413,449

FME Share Price Performance

Upcoming Events for FME

Full Year 2022 Fresenius Medical Care AG & Co KGaA Earnings Release

Full Year 2022 Fresenius Medical Care AG & Co KGaA Earnings Call

Fresenius Medical Care AG & Co KGaA at Morgan Stanley European MedTech & Services Conference

Q1 2023 Fresenius Medical Care AG & Co KGaA Earnings Release

Q1 2023 Fresenius Medical Care AG & Co KGaA Earnings Call

Fresenius Medical Care AG & Co KGaA Annual Shareholders Meeting

FAQ

Or unlock with your email

Or unlock with your email